News

Following are articles in which Putney is mentioned or founder Jean Hoffman is quoted, as well as presentations delivered by Putney.

These links are provided for educational and informational purposes only. Putney is not responsible for the content of those articles and presentations that are not sponsored by Putney.

Aug 9, 2010

Burlington Free Press

Former Shelburne Resident Fights for Generic Pet Meds

Jun 25, 2010

Time

One Ailing Pet Yields a Small Biz Juggernaut

Apr 20, 2010

National Public Radio, All Things Considered

Sold Documentaries On Public TV, Firms Get Ads

Mar 31, 2010

Pets News and Views

Would You Give Your Pets Generics?

Feb 17, 2010

Mass High Tech

IDEXX, Ventrex spark Maine's animal-oriented biotech cluster

Feb 17, 2010

Mass High Tech

Putney fights to open markets for pet generics

Feb 7, 2010

Portland Press Herald

Veterinary drug maker boosted by new capital

Sep 9, 2009

The Daily Cat

Are Generic Drugs Safe for Cats?

Aug 24, 2009

Maine Public Broadcasting Network

Portland Company Introduces Its First Generic Drug for Dogs

Aug 10, 2009

Mainebiz Magazine

Jean Hoffman Named 2009 Science & Technology Woman to Watch

Jul 20, 2009

NECN.com Business

Generic Pet Drugs

Jul 17, 2009

Mass High Tech

Drug companies see opportunity in pet generics

Jul 14, 2009

Mass High Tech

Startup Watch: Five you should follow

Jul 6, 2009

Veterinary Forum

Putney develops generic NSAID

Dec 19, 2008

Tech-EM

Tech-EM Chats with Christina Perkins, VP-Marketing at Putney

Dec 1, 2008

Mainebiz Magazine

Scripting success: A conversation with serial entrepreneur and pharmaceutical expert Jean Hoffman

Nov 26, 2008

Animal Pharm Companion Animal Products Conference

US Companion Animal Generics: Will the Human Generic Pattern Repeat?

Oct 17, 2008

Mass High Tech

Maine pharma startup targets generics for pets, vets

Sep 1, 2008

Journal of Generic Medicines

Veterinary generics: An engima among niche markets

Sep 27, 2006

Generic Drugs Summit

Predicting the Next Wave: Changes in the Global Generic Sector, Implications for Manufacturers and Investors